A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers
Clinical trial NCT02367196 · COMPLETED
Trial details
- NCT number
- NCT02367196
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-12
- Primary completion
- 2020-12-24
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.